This Article Full Text Full Text (PDF) All Versions of this Article: 42/2/166    most recent 01.HYP.0000082806.73530.68v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vecchione, C. Articles by Lembo, G. Search for Related Content PubMed PubMed Citation Articles by Vecchione, C. Articles by Lembo, G. Related Collections Endothelium/vascular type/nitric oxide Cell signalling/signal transduction

(Hypertension. 2003;42:166.)
© 2003 American Heart Association, Inc.

Scientific Contributions

Cooperation Between Insulin and Leptin in the Modulation of Vascular Tone

Carmine Vecchione; Alessandra Aretini; Angelo Maffei; Gennaro Marino; Giulio Selvetella; Roberta Poulet; Valentina Trimarco; Giacomo Frati; Giuseppe Lembo

From the Department of Angio-Cardio-Neurology (C.V., A.A., A.M., G.M., G.S., R.P., V.T., G.F., G.L.), IRCCS Neuromed, Pozzilli (IS), and the Department of Experimental Medicine and Pathology (G.L.), La Sapienza University, Rome, Italy.

Correspondence to Giuseppe Lembo, MD, PhD, IRCCS Neuromed, Località Camerelle, 86077 Pozzilli (IS), Italy. E-mail lembo{at}neuromed.it

High levels of insulin and leptin have been reported in human hypertension, suggesting a role for these metabolic hormones in blood pressure homeostasis. These hormones interact on intermediate metabolism, but nothing is known about their interaction at the vascular level. Our data demonstrate that insulin (0.6 nmol/L) is able to enhance vasodilation induced by leptin (10^-11 to 10^-6 mol/L; percentage change in maximal vasodilation, 39±3% vs 26±2%; n=6, P<0.03) but not by acetylcholine. Moreover, we demonstrate by 4,5-diaminofluorescein (DAF)-2 that insulin potentiates leptin-induced nitric oxide (NO) release. Finally, Western blotting studies show that insulin enhances the leptin-induced phosphorylation of Akt in Ser⁴⁷³ and Thr³⁰⁸ and of endothelial NO synthase in Ser¹¹⁷⁷. In conclusion, our data demonstrate that insulin and leptin cooperate in the modulation of vascular tone through enhancement of endothelial NO release. This phenomenon could have a major impact on the regulation of the cardiovascular system, principally in those clinical conditions characterized by endothelial NO dysfunction and metabolic disorders, such as arterial hypertension.

Key Words: insulin • leptin • endothelium-derived factors • nitric oxide synthase • phosphorylation • vasorelaxation

This article has been cited by other articles:

				K. K. Koh, S. M. Park, and M. J. Quon Leptin and Cardiovascular Disease: Response to Therapeutic Interventions Circulation, June 24, 2008; 117(25): 3238 - 3249. [Full Text] [PDF]

				M. T. Gentile, C. Vecchione, G. Marino, A. Aretini, A. Di Pardo, G. Antenucci, A. Maffei, G. Cifelli, L. Iorio, A. Landolfi, et al. Resistin Impairs Insulin-Evoked Vasodilation Diabetes, March 1, 2008; 57(3): 577 - 583. [Abstract] [Full Text] [PDF]

				R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon Cardiovascular Actions of Insulin Endocr. Rev., August 1, 2007; 28(5): 463 - 491. [Abstract] [Full Text] [PDF]

				A. Rodriguez, A. Fortuno, J. Gomez-Ambrosi, G. Zalba, J. Diez, and G. Fruhbeck The Inhibitory Effect of Leptin on Angiotensin II-Induced Vasoconstriction in Vascular Smooth Muscle Cells Is Mediated via a Nitric Oxide-Dependent Mechanism Endocrinology, January 1, 2007; 148(1): 324 - 331. [Abstract] [Full Text] [PDF]

				J. Nigro, N. Osman, A. M. Dart, and P. J. Little Insulin Resistance and Atherosclerosis Endocr. Rev., May 1, 2006; 27(3): 242 - 259. [Abstract] [Full Text] [PDF]

				P. M. Thule, A. G. Campbell, D. J. Kleinhenz, D. E. Olson, J. J. Boutwell, R. L. Sutliff, and C. M. Hart Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E114 - E122. [Abstract] [Full Text] [PDF]

				C. Vecchione, E. Patrucco, G. Marino, L. Barberis, R. Poulet, A. Aretini, A. Maffei, M. T. Gentile, M. Storto, O. Azzolino, et al. Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3K{gamma} J. Exp. Med., April 18, 2005; 201(8): 1217 - 1228. [Abstract] [Full Text] [PDF]

				S. H. Schirmer, I. R. Buschmann, M. M. Jost, I. E. Hoefer, S. Grundmann, J.-P. Andert, S. Ulusans, C. Bode, J. J. Piek, and N. van Royen Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis Cardiovasc Res, November 1, 2004; 64(2): 356 - 364. [Abstract] [Full Text] [PDF]

				K. Tsuda, I. Nishio, C. Vecchione, and G. Lembo Insulin, Leptin, and Membrane Microviscosity in Blood Pressure Regulation * Response: Insulin-Leptin Interplay May Differ Among Tissues Hypertension, April 1, 2004; 43(4): e15 - e16. [Full Text] [PDF]